A multicentre, randomised trial of bendamustine in combination with rituximab versus R-CHOP in patients with frontline low-grade B-Cell non-Hodgkin's lymphoma or mantle cell lymphoma

Trial Profile

A multicentre, randomised trial of bendamustine in combination with rituximab versus R-CHOP in patients with frontline low-grade B-Cell non-Hodgkin's lymphoma or mantle cell lymphoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Bendamustine (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Rituximab; Vincristine
  • Indications Mantle-cell lymphoma; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2013 Status changed from recruiting to active, no longer recruiting, as reported in a SymBio media release.
    • 07 Jan 2013 This trial was ongoing in January 2013, according to a SymBio Pharmaceuticals media release.
    • 21 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top